Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine.
10.4168/aair.2017.9.4.299
- Author:
Dae Woo KIM
1
;
Seong H CHO
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Boramae Medical Center, Seoul, Korea.
- Publication Type:Review
- Keywords:
Nasal polyps;
chronic rhinosinusitis;
endotypes;
phenotypes;
biologicals;
cytokines
- MeSH:
Asthma;
Cytokines;
Epithelial Cells;
Immunoglobulin E;
Immunoglobulins;
Interleukin-13;
Interleukin-33;
Interleukin-4;
Interleukin-5;
Interleukins;
Lymphocytes;
Nasal Polyps;
Phenotype;
Precision Medicine*;
Prognosis;
T-Lymphocytes
- From:Allergy, Asthma & Immunology Research
2017;9(4):299-306
- CountryRepublic of Korea
- Language:English
-
Abstract:
Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease with various underlying pathophysiologic mechanisms which translate to endotypes, in contrast to clinical phenotypes or histological subtypes. Defining endotypes can help clinicians predict disease prognosis, select subjects suitable for a specific therapy, and assess risks for comorbid conditions, including asthma. Therefore, with recent advancement of biologicals in CRS clinical trials, endotyping can be a breakthrough in treating recalcitrant CRS. CRS is caused by dysregulated immunologic responses to external stimuli, which induce various inflammatory mediators from inflammatory cells, including innate lymphoid cells (ILCs) and T lymphocytes as well as epithelial cells. Thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, which are mainly secreted by epithelial cells in response to external stimuli, act on type 2 ILCs and T helper 2 (Th2) cells, inducing IL-4, IL-5, and IL-13. Local immunoglobulin E (IgE) production is also a signature event in nasal polyps (NP). These inflammatory mediators are novel potential therapeutic targets for recalcitrant CRS. This article reviews recent publications regarding endotypes and endotype-based therapeutic strategies in CRS and NP.
